BRIEF published on 08/25/2026 at 19:35, 2 months 14 days ago New CEO Appointed at KD Pharma Group Pharmaceutical Industry Leadership Change KD Pharma Group Omega-3 Lipids Manja Boerman
BRIEF published on 08/25/2026 at 19:35, 2 months 14 days ago Nomination d'un nouveau PDG chez KD Pharma Group Changement De Leadership Industrie Pharmaceutique Groupe KD Pharma Manja Boerman Lipides Oméga-3
PRESS RELEASE published on 08/25/2026 at 19:30, 2 months 14 days ago Change in the Management Board O3 Holding GmbH announces the appointment of Manja Boerman as Chief Executive Officer of KD Pharma Group, bringing extensive industry expertise in pharmaceutical, biotechnology, and life sciences Pharmaceutical Industry Chief Executive Officer O3 Holding GmbH KD Pharma Group Manja Boerman
BRIEF published on 08/21/2026 at 15:20, 2 months 18 days ago O3 Holding GmbH Releases Q2 2026 Interim Report Bond Issue O3 Holding GmbH KD Pharma Group Q2 2026 Report Pharmaceutical Lipids
BRIEF published on 08/21/2026 at 15:20, 2 months 18 days ago O3 Holding GmbH publie son rapport intermédiaire du deuxième trimestre 2026 Emission D'obligations O3 Holding GmbH Groupe KD Pharma Rapport Du Deuxième Trimestre 2026 Lipides Pharmaceutiques
PRESS RELEASE published on 08/21/2026 at 15:15, 2 months 18 days ago O3 Holding GmbH - Publication Q2 2026 Interim Report O3 Holding GmbH, the parent company of KD Pharma Group, releases Q2 2026 Interim Report in compliance with bond terms, available on their website Pharmaceutical O3 Holding GmbH KD Pharma Group Q2 2026 Interim Report Nutritional Lipids
BRIEF published on 05/29/2026 at 18:05, 5 months 10 days ago O3 Holding GmbH Releases Q1 2026 Interim Report Financial Disclosure Bond Issue O3 Holding GmbH KD Pharma Group Q1 2026 Report
BRIEF published on 05/29/2026 at 18:05, 5 months 10 days ago O3 Holding GmbH publie son rapport intermédiaire du premier trimestre 2026 Déclaration Financière Emission D'obligations O3 Holding GmbH Groupe KD Pharma Rapport Du Premier Trimestre 2026
PRESS RELEASE published on 05/29/2026 at 18:00, 5 months 10 days ago O3 Holding GmbH - Publication Q1 2026 Interim Report O3 Holding GmbH announces the publication of its Q1 2026 Interim Report for its FRN Senior Secured EUR 180,000,000 bond issue. Contact investor.relations@kdpharma.com for more info CDMO Interim Report Q1 2026 O3 Holding GmbH KD Pharma Group
BRIEF published on 03/02/2026 at 11:40, 8 months 6 days ago O3 Holding GmbH Releases Q4 2025 Interim Report Financial Results Bond Issue O3 Holding GmbH KD Pharma Group Q4 2025 Interim Report
Published on 11/06/2026 at 22:15, 2 days 8 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 18 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 01:55, 5 hours 12 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 18 hours 56 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 20 hours 51 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day 17 hours ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 2 days 10 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/09/2026 at 07:00, 7 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 7 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 7 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 7 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
